Organ-on-a-chip

#CN Bio #Drug discovery #Events #Life sciences #Organ-on-a-chip #R&D

Speaker line-up and scientific programme for organ-on-a-chip e-symposium 

The full scientific programme for the 2026 ‘From Insight to Decision’ e-symposium, which is taking place on 2 and 8 December, has been announced by CN Bio. The event will feature expert-led sessions offering practical, real-world guidance on organ-on-a-chip (OOC) use within existing R&D strategies.  Launched in… Read More

#News

Kidney on a chip technology
#CN Bio #Innovate UK #New approach methodologies (NAMs) #Organ-on-a-chip

CN Bio awarded Innovate UK grant to reduce animal testing

CN Bio, a provider of organ-on-a-chip (OOC) systems, has been awarded £180k ($243k) grant funding from Innovate UK.   Delivered in partnership with the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), the funding aims to support new approach methodologies (NAMs) for use in drug… Read More

#Business & Investment #News

#AlveoliX #Francis Crick Institute #Lung disease #New approach methodologies (NAMs) #Organ-on-a-chip

First ‘lung-on-chip’ developed using genetically identical cells

Researchers at the Francis Crick Institute and AlveoliX have developed the first human ‘lung-on-chip’ model using stem cells taken from only one person.  These chips simulate breathing motions and lung disease in an individual, holding promise for testing treatments for infections like tuberculosis (TB) and delivering personalised… Read More

#Editor's Choice #News

#AI / data analytics / healthtech / informatics #Drug discovery #Non-animal model (NAM) #Organ-on-a-chip #Preclinical development

What comes after animal models?  

Mariana Argenziano, Associate Director Manufacturing Technologies, and Jeroen de Groot, Divisional Chief Executive Officer at Ncardia, explore how human-relevant preclinical research can move the industry past its reliance on animal models.   In April 2025, the US Food and Drug Administration (FDA) released a roadmap to reducing animal testing in preclinical… Read More

#Exclusive Content

Organ-on-a-chip
#Drug discovery #Emulate #High throughput screening #Organ-on-a-chip

Emulate launches unique high-throughput organ-chip platform

Emulate has launched the AVA Emulation System, a self-contained instrument that cultures, incubates, and images up to 96 independent organ-chip samples in a single run.   The company says that AVA delivers an unprecedented magnitude of in vivo-level insights faster than animal models while cutting consumable… Read More

#News

#CN Bio #Human disease models #Organ-on-a-chip #Partnership

CN Bio signs distributor agreement in South Korea

Organ-on-a-chip (OOC) company CN Bio has agreed a strategic partnership with SCINCO, a specialist scientific instrument company based in South Korea.   The agreement is designed to amplify the CN Bio’s presence in major Asian and Pacific markets and broaden access to its predictive human organ models.  CN Bio is establishing… Read More

#Business & Investment #News

#AI / data analytics / healthtech / informatics #Cancer research #Drug discovery #Emulate #Gene expression #Gene therapy #Interview #Metabolomics #Multi-omics #Next generation sequencing #NGS #Omics #Organ-on-a-chip #Personalised medicine #Preclinical investigations #Spatial biology

Podcast: Cutting-edge tools shaping early-stage drug discovery

This is the latest episode of the free DDW narrated podcast, titled “Cutting-edge tools shaping early-stage drug discovery”, which covers three articles written for DDW Volume 24 – Issue 4, Fall 2023. They are called: “The use-case for NGS”, “Are organ-chips the future of preclinical… Read More

#News

Organ-on-a-chip
#eBook #Human disease models #In vitro #Non-animal model (NAM) #Organ-on-a-chip

What are the benefits of organ-on-a-chip technology?

Organ-Chips have seen significant growth in adoption over the past few years. A blinded survey across industry and academia found: 97% of experienced Organ-Chip users say the technology is more predictive than conventional in vitro models. 70% of experienced Organ-Chip users describe the technology as more predictive than… Read More

#News

Emulate eBook
#Human disease models #In vitro #Non-animal model (NAM) #Organ-on-a-chip

Unlock Human-Relevant Insights with Organ-on-a-Chip Technology

Organ-Chips have seen significant growth in adoption over the past few years. A blinded survey across industry and academia found: 97% of experienced Organ-Chip users say the technology is more predictive than conventional in vitro models. 70% of experienced Organ-Chip users describe the technology as more predictive than… Read More

#Resources

#CN Bio #Funding #Investment #Organ-on-a-chip

CN Bio raises $21 million in Series B investment round

Organ-on-a-chip (OOC) company CN Bio has raised a $21 million investment in the first close of its Series B fundraising round. The funding has been secured from several new investors; including $10 million from Bayland Capital, and $5.5 million from founding shareholder, CN Innovations Holdings Ltd. The investment will be… Read More

#Business & Investment #News

Kidney on a chip technology
#Kidney disease #Organ-on-a-chip #Organoids #Preclinical investigations #University of Washington

Kidney platforms could reduce animal testing in tox studies

Kidney disease researchers at the University of Washington will use a multimillion-dollar federal grant to advance drug development platforms that would reduce reliance on animal tests. The investigators, in the UW schools of Medicine and Pharmacy, received the $7.3 million award from the National Center for… Read More

#News

Organ-on-a-chip
#CN Bio #Inipharm #Liver disease #Organ-on-a-chip #Phase I trial #Preclinical investigations

Organ-on-a-chip data supports progression of liver disease drug

Inipharm has initiated Phase I dosing of its lead candidate, INI-822, which is a small-molecule inhibitor for HSD17B13, a gene implicated in nonalcoholic steatohepatitis (NASH). Loss-of-function variants of HSD17B13 are known to be associated with reduced incidence risk and severity of multiple liver diseases. Read More

#News

#Awards #CN Bio #Collaboration #FDA #OBN Awards #Organ-on-a-chip

CN Bio named winner with most impactful industry collaboration  

CN Bio, an organ-on-a-chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems (MPS), has received the ‘Most Impactful Industry Collaboration of the Year’ at the 2023 OBN Awards.   The award recognises the ongoing success of the company’s collaboration with the US Food and Drug Administration… Read More

#News

Organ-on-a-chip
#Cancer research #Emulate #Gene therapy #Organ-on-a-chip #Preclinical investigations

Are organ-chips the future of preclinical research?

Listen to this article on the DDW Podcast: Diana Spencer catches up with Lorna Ewart, PhD, Chief Scientific Officer of Emulate, about the rise of organ-on-a-chip technology. Organ-chips combine cell culture with microfluidics to emulate the biological forces of different organ tissues and/or disease states, allowing pharmaceutical researchers to determine a… Read More

#Exclusive Content

Human heart model
#Adverse event #Cardiovascular disease #Drug safety #Drug screening #iPSC #Organ-on-a-chip

Miniature human heart has potential to reshape drug testing

A tiny human heart model could potentially transform cardiovascular research and enable animal-free drug testing. A team of researchers, led by the Hebrew University of Jerusalem (HU), has developed a self-paced, multi-chambered human heart model, approximately half the size of a rice grain. “Integrating… Read More

#Editor's Choice #News

#Drug development #Drug discovery #Emulate #Organ-on-a-chip

An introduction to organ-on-a-chip technology

Download Emulate’s Introduction to Organ-on-a-Chip Technology eBook to learn about: What Organ-Chips are, how they work, and why they are transforming the way drugs are discovered and developed How Organ-Chips overcome the main challenges of conventional in vivo and in vitro models The wide variety of insights and endpoint analyses… Read More

#Resources